Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Animalcare ( (GB:ANCR) ) has shared an update.
Animalcare, an international animal health business, reported 2025 revenue up 20% to £89.1m, driven largely by the acquisition and integration of Randlab and modest like-for-like growth across all product categories. Underlying EBITDA rose 52.6% to £17.7m with margins improving to 20.6%, while net debt remained low at £9.1m and leverage at 0.7 times, supporting continued investment.
Flagship brands Daxocox, Plaqtiv+ and Orozyme delivered strong double‑digit growth, aided by new indications and launches, and equine now accounts for nearly a quarter of group revenue. The group expanded its Asia-Pacific footprint via Randlab and a 25% stake in Australian firm InVetro, boosted R&D to 4.5% of revenue and added new biological pain and equine therapies, while the board agreed a recommended takeover by a Charterhouse‑backed vehicle and proposed no final dividend ahead of the deal.
Spark’s Take on ANCR Stock
According to Spark, TipRanks’ AI Analyst, ANCR is a Neutral.
Animalcare’s overall stock score reflects strong financial stability and positive corporate events, which are offset by valuation concerns due to a negative P/E ratio. Technical indicators suggest moderate potential for price appreciation. The company’s strategic initiatives and director’s confidence are significant positives.
To see Spark’s full report on ANCR stock, click here.
More about Animalcare
Animalcare Group is a UK AIM-listed international veterinary sales and marketing company focused on animal health. It operates in seven European countries as well as Australia, New Zealand and the UAE, and exports to about 40 markets, concentrating on innovative companion animal and equine products developed in-house, via partnerships and through acquisitions.
Average Trading Volume: 369,854
Technical Sentiment Signal: Strong Buy
Current Market Cap: £229.6M
See more insights into ANCR stock on TipRanks’ Stock Analysis page.